Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Alkem Laboratories Ltd.
NSE: ALKEM
|
BSE: 539523
|
ISIN: INE540L01014
|
Industry: Pharmaceuticals
|
Mid-range Performer
4906.5000
65.50
(
1.35
%)
NSE
Jun 27, 2025
15:31 PM
Volume:
113.9K
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Alkem Laboratories Ltd.
26 May 2021
4906.50
1.35%
Alkem Labs (BUY): Poor US sales and inventory provision affect Q4
Buy:
Alkem Laboratories Ltd.
by
BOB Capital Markets Ltd.
Target: 3620
Target
BOB Capital Markets Ltd.
Alkem Labs reported a below-expected Q4FY21 with +7%/4% YoY sales/EBITDA growth.
Number of FII/FPI investors increased from 524 to 535 in Mar 2025 qtr.
More from Alkem Laboratories Ltd.
Recommended
Five Interesting Stocks Today - June 27, 2025
The Baseline |
27 Jun 2025
Market closes higher, Ahluwalia bags Rs 1,103.6 crore residential projects in Gurugram and Bengaluru
Trendlyne Marketwatch |
27 Jun 2025
Alkem Laboratories hopes to fire up its US business to fuel future growth
|
02 Jul 2021